8-K

UNITED STATES

 SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

____________

FORM 8-K

CURRENT REPORT

     PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): May 13, 2016

CHROMADEX CORPORATION

 (Exact name of registrant as specified in its charter)

Delaware	000-53290	26-2940963
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

10005 Muirlands Boulevard, Suite G, Irvine, California, 92618

(Address of principal executive offices, including zip code)

(949) 419-0288

 (Registrant's telephone number, including area code)

Copies to:

Harvey Kesner, Esq.

61 Broadway, 32nd Floor

New York, New York 10006

Phone: (212) 930-9700

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[   ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[   ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[   ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[   ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On May 13, 2016, Hugh Dunkerley, a member of the Board of Directors (the “Board”) of ChromaDex Corporation (the “Company”), resigned from the Board and as a member of the compensation committee of the Board (the “Compensation Committee”). Mr. Dunkerley’s resignation was not the result of any disagreements with the Company’s operations, policies, or practices.  As a result of his departure from the Board, Mr. Dunkerley will no longer be standing for re-election to the Board at the Company’s Annual Meeting of Shareholders on June 2, 2016.  Also on May 13, 2016, the Board appointed Reid Dabney, a current Board member, to serve on the Compensation Committee and reduced the size of the Board to six members from seven members.  Mr. Dabney shall remain on the Board’s Audit Committee as chairperson and as the Company’s Audit Committee financial expert.

Item 9.01  Financial Statements and Exhibits

(d)           Exhibits.

The exhibit listed in the following Exhibit Index is furnished as part of this Current Report on Form 8-K.

Exhibit No.	Description
99.1	Letter of resignation of Mr. Hugh Dunkerley, dated May 13, 2016

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

                                  CHROMADEX CORPORATION

Dated: May 13, 2016   By:  /s/ Frank L. Jaksch Jr. Name: Frank L. Jaksch Jr. Title: Chief Executive Officer

EX-99.1

Exhibit 99.1

RESIGNATION LETTER

May 13, 2016

Chairman of the Board

Chromades Corporation

10005 Muirlands Blvd.

Suite G

Irvine, California 92616

Dear Mr. Allen:

Effective immediately I hereby tender my resignation form all positions with ChromaDex Corporation (the “Company”), including as a member of the board of directors and as a member of the compensation committee of the board of directors.

Please note that my resignation is not as a result of any disagreement between myself and the Company, its management, board of directors or any committee of the board of directors.

Sincerely,

/s/ Hugh Dunkerley

Hugh Dunkerley